A common objective of biomarker studies is to develop a predictor of patient survival outcome. Determining the number of samples required to train a predictor from survival data is important for designing such studies. Existing sample size methods for training studies use parametric models for the high-dimensional data and cannot handle a right-censored dependent variable. We present a new training sample size method that is non-parametric with respect to the high-dimensional vectors, and is developed for a right-censored response. The method can be applied to any prediction algorithm that satisfies a set of conditions. The sample size is chosen so that the expected performance of the predictor is within a user-defined tolerance of optimal. The central method is based on a pilot dataset. To quantify uncertainty, a method to construct a confidence interval for the tolerance is developed. Adequacy of the size of the pilot dataset is discussed. An alternative model-based version of our method for estimating the tolerance when no adequate pilot dataset is available is presented. The model-based method requires a covariance matrix be specified, but we show that the identity covariance matrix provides adequate sample size when the user specifies three key quantities. Application of the sample size method to two microarray datasets is discussed.
INTRODUCTION
Modern biological assays are often expensive and complex laboratory procedures. Many assays have moved beyond the initial "proof of principle" phase, and their predictive strength is being evaluated. An example is the National Cancer Institute's Director's Challenge Lung Study (DCLS), which was designed to study gene expression signatures in lung cancer based on previous smaller studies that had shown a prediction signal existed that could be used to separate patients with good prognosis from those with poor prognosis (e.g. Beer and others, 2002) . The first author took part in the sample size calculations for the DCLS, which used parametric assumptions and a simplified model. This paper's objective is to develop a more careful approach to sample size estimation.
Determining sample size in high-dimensional studies is critical to prevent either undersized studiesthat lead to inconclusive or erroneously negative findings-or wasteful oversized studies. The sample size method developed here is appropriate for studies utilizing right-censored survival data and biological assay A univariate Cox regression was fit to each feature to establish association with survival, and a multifeature signature using 572 genes associated with survival in the training set was validated in an independent dataset after binarizing the survival predictions. The existence of signatures in ovarian cancer is less well established than in breast cancer. The study identified a prognostic signature in only a subset of the patients.
This paper is organized as follows. Section 2 presents an overview of the method. Section 3 presents the statistical model, definitions, and assumptions. Section 4 presents the estimation procedures in general. Section 5 demonstrates implementation of the method. Sections 6 and 7 present simulation studies, resampling studies, and real data applications. Finally, Section 8 presents summaries and conclusions.
OVERVIEW OF APPROACH
A training set can be used to develop a risk predictor. For a future patient, the risk predictor will assign a numerical value to that patient indicating the risk of disease recurrence or death (e.g. larger values indicate higher risk). But this risk score is an estimated value, and it is conditional on the training set. If a different training set is used, a different risk score will likely be assigned to the patient. This variation is analogous to measurement error variation. The measurement error is just a prediction error due to the limited training set. Under regularity conditions (Section 3 of supplementary material available at Biostatistics online) the prediction error will decrease stochastically as the training sample size, say n, increases (Section 4, Theorem 1 of supplementary material available at Biostatistics online). In the limit, as n goes to infinity, the prediction error will go to zero. A zero prediction error is in this way analogous to the zero measurement error. EIVs regression methods are used to recover the regression relationship between a response and the predictor when the predictor is measured with error. So, to estimate the relation between survival (the response) and the optimal risk scores, EIVs regression can be used. This reasoning leads to the sample size method shown in Figure 1 .
As shown in Figure 1 , the method is based on a pilot dataset. The steps shown are: (1) select n * n at random (without replacement) from the pilot dataset; (2) estimate the prediction performance for a training sample of size n * using cross-validation (CV); (3) estimate the variance of the risk score estimates by the tuned LOOBS; (4) combine the results of steps (2) and (3) to estimate the optimal performance by EIVs regression; (5) combine steps (2) and (4) to estimate the tolerance (distance from optimal, defined K. K. DOBBIN AND X. SONG below) for n * ; (6) estimate the learning curve from the pilot dataset using subsets of different sizes-the learning curve describes the relation between the training set size and the expected predictor performance; (7) use the results of step (6) to determine the sample size that will guarantee that the expected predictor performance is within a specified tolerance of the asymptotic performance.
THE STATISTICAL MODEL
The pilot dataset will contain n patients' data, consisting of vectors g 1 , . . . , g n , each of dimension p. With all patients are associated failure times T 1 , . . . , T n and censoring times C 1 , . . . , C n , which are all mutually independent. The observed quantities are Y i = min(C i , T i ) and failure indicators δ i = 1 {T i C i } , for i = 1, . . . , n. The failure time T i is assumed to be completely described by the hazard rate
The most commonly used model in this setting is the Cox proportional hazards model
where β ∞ is a scalar, and λ 0 (t) the baseline hazard function. In the Cox model, the slope parameter β ∞ will change if the X i are rescaled (e.g. X i → cX i , c > 0). Also, a mean shift in the X i (e.g. X i → X i + c, c ∈ 1 ) results in a change in the definition of the nuisance baseline hazard λ 0 (t). So, to ensure identifiability, one assumes the X i have mean 0 and variance 1. In real data applications, the variance of the risk scores may not be unity without first rescaling them. The β ∞ is the change in the log-hazard associated with an increase of one standard deviation in the asymptotic risk scores, and rescaling will change the standard deviation.
The X i above we call the asymptotic risk scores. They are the limit of the estimated risk scores of a risk prediction algorithm. Under regularity conditions given in supplementary material available at Biostatistics online (Section 3), a patient i's estimated risk score will converge in quadratic mean to a scalar value X i as the training sample size increases.
An algorithm applied to a training set, say j, results in a function that maps p to 1 . The resulting function, sayf j , is assumed to be deterministic, so that we can writef j :
p → 1 (Section 3, condition 1 of supplementary material available at Biostatistics online).
Unlike traditional Cox regression contexts, the asymptotic risk scores X i are not observed directly.
Here f is an unknown function that maps the high-dimensional data into the asymptotic risk scores. Let W i j =f j (g i ). We relate the asymptotic risk scores to the estimated risk scores by a simple additive error model:
Here U i j represents prediction error with zero mean. The notation W i j is used instead ofX i j to facilitate comparison with Carroll and others (2006) .
Obtainingf
In this paper, we focus on the sample size method once the algorithm forf is determined. But in practice, selection of an appropriate prognostic predictor training functionf itself is critical. The functionf must satisfy the following conditions: (1) the prediction scores produced byf must converge in quadratic mean to the true scores (for details, see Section 3.1 of supplementary material available at Biostatistics online) and (2) the rate of convergence must be fast enough that the learning curve can be adequately estimated from the pilot dataset. Condition (2) implies that one should pick the algorithm with the fastest possible learning rate. There will typically be algorithms that are widely accepted. For microarrays, examples include (1) PDA1 described below, (2) Lasso Cox regression (Tibshirani, 1996) , and (3) elastic net Cox regression (Simon and others, 2011) . See Witten and Tibshirani (2010) for comparisons of procedures. These three produce linear predictors, use the survival information, and are suited to high-dimensional low sample size contexts.
3.2 Defining E n , Var n , σ 2 n , and Tol(n) Define the notation E n and Var n as the expectation and variance, respectively, taken over training sets of size n in the population. Intuitively, one imagines drawing independent samples of size n at random repeatedly from the target population, and each time constructing a risk predictor. This results inf 1 ,f 2 , . . .-an infinite sequence of risk predictors, across which means and variances are taken.
Under this notation, the variance of an individual's estimated risk score for a fixed training size n is Var n (f j (g i )). We will make the simplifying assumption that the prediction error variances are the same for all individuals i, that is,
If, for a fixed training set j, a Cox regression of survival on all the estimated risk scores W i j in the population is performed, under certain regularity conditions (Section 4.3 of supplementary material available at Biostatistics online) this will produce a slope estimateβ j . For two different training samples of size n, say j 1 = j 2 , the slopes may be different, that is,β j 1 =β j 2 . Under regularity conditions (Section 4.3 of supplementary material available at Biostatistics online and Li and Ryan, 2004 ), E n [β j ] = β n exists and |β n | < |β ∞ |. β n is shrunken toward zero. The tolerance is defined as Tol(n) = |β ∞ − β n |.
ESTIMATION
Briefly, for subsets of different sizes, first β n is estimated by CV, then σ 2 n is estimated by the tuned LOOBS, and finally the tolerance is estimated by EIVs regression. For details, see Section 2 of supplementary material available at Biostatistics online.
The β ∞ is the Cox regression slope associated with an infinite training set. The risk scores estimated from CV, W i j , and the LOOBS variance estimate,σ 2 n , are combined with the survival data in an EIVs Cox regression. Similar to Tsiatis and Davidian (2001) , the conditional score approach we use assumes that
2 ). As shown in Figure S1 of supplementary material available at Biostatistics online (Section 1.7), homogeneity of the error variance appeared reasonable, so the heterogeneous model was not investigated in depth. Suppose one wants to estimate β ∞ using the jth training set. Let N i (u) = I (Y i u, δ i = 1) be the counting process for the failure time, and
where
The tolerance is the absolute value of the difference between the mean Cox regression slope for a sample of size n * and the asymptotic slope. The estimate of Tol(n * ) is Tol(n * ) = |β ∞ −β n * |, whereβ ∞ is the slope estimate from the conditional score regression using the n * in the working training set, andβ n * is from the CV (Section 2 of supplementary material available at Biostatistics online).
Note that predicting the sample size associated with a desired tolerance is analogous to a regression prediction problem. First transform the tolerance using a Box-Cox transformation (Box and Cox, 1964) to linearize the relationship. Letĥ() be the estimated transformation of the tolerance. Finally, fit the linear regression model n * = ζ + ξ ×ĥ( Tol(n * )) producing the ordinary least-squares estimateŝ ζ andξ . Let t target be the targeted tolerance, which is specified by the user. The sample size estimate isn =ζ +ξ ×ĥ(t target ). The sample size algorithm is given in Section 2.3 of supplementary material available at Biostatistics online.
Constructing a confidence interval for the tolerance
The sample size estimaten does not reflect the uncertainty in the estimation procedure. This uncertainty can be assessed in a confidence interval for the tolerance. Let n 0 be the proposed sample size. Let R be the tolerance. The Box-Cox regression model is
R be the ordinary least-squares estimates from the Box-Cox regression. The confidence interval formula, derived in Section 5 of supplementary material available at Biostatistics online, is
A similar result is presented in Collins (1991). We performed a simulation to evaluate the procedure.
Results are also discussed in Section 5 of supplementary material available at Biostatistics online as well.
HIGH-DIMENSIONAL EXAMPLE
The risk predictor method used in this paper's examples is similar to the method used in Beer and others (2002) . Denote the method by PDA1. Roughly, in PDA1, features are selected based on univariate score test p-values, then weighted by univariate Cox regression coefficients. Details are provided in Section 2.2 of supplementary material available at Biostatistics online.
The tuned LOOBS on PDA1
PDA1 selects features with score test p-values below a cutoff stringency level, such as α = 0.001. Denote byβ * k the estimated slope from a univariate Cox regression on feature k applied to a bootstrap sample. Let I (β * k ) be the observed information for feature k based on the univariate partial likelihood of the bootstrap sample. To approximately preserve the nominal significance level, feature k is selected during bootstrap
While maintaining approximate significance level (Sections 1.2 and 4.6 of supplementary material available at Biostatistics online), this approach results in loss of bootstrap power compared with cross-validated power. The power lost is that associated with multiplying the standard error by roughly (2) 1/2 ≈ 1.41.
Tolerance estimation without a pilot dataset
A pilot dataset may not be available or may not be adequate as discussed below. Our approach can be adapted to that setting by assuming high-dimensional data are multivariate normal and survival is exponential. A combination of mathematics and Monte Carlo are used to estimate the tolerance. A key step is to estimate the prediction error variance σ 2 with trace( VL ) where is the population covariance andVL is the covariance estimate of the linear predictor. Details are presented in Section 5 of supplementary material available at Biostatistics online. 
where σ ab is the (a, b) th element of the covariance matrix , and l j is the jth element of L. Therefore, only the identity covariance matrix need be used in practice. Users of the program should restrict simulations to settings where there is at least 70% power to detect survival features (otherwise a warning message appears). The program can currently be used with PDA1 or the lasso (Tibshirani, 1996) .
SIMULATION STUDIES
For all simulations, survival data were generated with baseline hazard exponential with mean 1, or with Weibull where noted. Censoring times were exponential with mean 3. The follow-up time was stopped at 4. High-dimensional data for features not associated with survival were generated as multivariate normal (or T where noted), with zero mean and identity covariance. Survival-related features were generated as indicated in the text and supplementary material available at Biostatistics online. Dimension was set at p = 1000 except where noted differently. Computation was carried out in C++ on a Borland 5.0 compiler using Optivec and IMSL vector and matrix libraries, and R version 2.15.2.
Simulation evaluation of the tuned LOOBS appears in Section 1.2 of supplementary material available at Biostatistics online, where it is shown to reduce the bias of the simple LOOBS. Table 1 (and Section 1.1 tables of supplementary material available at Biostatistics online) shows the estimation of β ∞ for a variety of settings. Table 1 presents a scenario with 30 survival-associated features in a block compound symmetric covariance structure. As can be seen from the tables,β ∞ is close to unbiased in most cases. The β ∞ estimate tends to do better in cases where the feature selection stringency is appropriate to the data, and to break down in cases where the stringency is too lax (e.g. first row of first table in Section 1 of supplementary material available at Biostatistics online) or too strict (e.g. Table 1 when α = 0.0001). Overall, the slope estimates do well at recovering the asymptotic slope for these sample sizes (n = 300 and about 200 events/deaths). Table 2 shows the estimated sample sizes for a range of simulation settings, along with a pure Monte Carlo evaluation of the adequacy of the sample size estimates (rightmost two columns). In all cases, the estimated sample size results in a mean slope that is within the specified tolerance. The raw slopes are also within the tolerance value 56-99% of the time (rightmost column). (The raw slope is analogous to actual prediction error, and the mean slope is analogous to expected prediction error. To clarify this distinction, see, e.g. Dobbin, 2009 .) The method is most conservative in the two cases when there are 30 informative features and the tolerance is set to the largest level of 0.30. In other settings, however, the method seems only mildly conservative.
Robustness of our method to poor power to detect survival features in the pilot dataset was evaluated by systematically generating datasets with smaller and smaller effects. Results are shown and discussed in Section 1.3 of supplementary material available at Biostatistics online. Power of at least 70% to detect survival-related features is recommended, because without these features the asymptotic performance estimate cannot be relied upon. Now we turn to evaluation of the model-based tolerance estimation method, investigating robustness to model violations using pure Monte Carlo and resampling studies. The Monte Carlo robustness studies generated data from high-dimensional multivariate T distributions with 5 and 10 degrees of freedom, Simulation settings have n = 300 patients. High-dimensional feature covariance matrix has 30 informative features, in three compound symmetric blocks of size 10, within-block correlation 0.7, between-block correlation 0. B = 35 bootstraps in the LOOBS loop. Column headings are: α column is the stringency used for feature selection; β ∞ is the optimal Cox regression slope.β ∞ is the estimate of the optimal slope produced by our method.σ 2 bs is the estimate of prediction error variance from the tuned LOOBS.β cv =βW /{1 +σ 2 bs } 1/2 (whereβW is the raw slope that comes out of CV) is the estimated slope from 10-fold CV for the full dataset predictor developed from n samples. and accelerated failure time survival distributions with increasing and decreasing hazard. The modelbased estimates were robust to these model violations (Section 1.5 of supplementary material available at Biostatistics online). In most settings, the estimated tolerance is within 0.05 of the true tolerance, the exception being certain cases of a heavy-tailed multivariate T with 5 d.f. and correlated features. For resampling evaluation, we used two large survival datasets, the Rosenwald and others (2002) dataset of leukemia, and the Loi and others (2007) dataset of breast cancer. Table 3 shows the results. Since resampling will not provide aβ ∞ , we instead use the tolerance associated with large sample sizes. For the Rosenwald dataset, we estimateβ 240 −β n . For the Loi dataset, we estimateβ 327 −β n . We estimate each by pure resampling first (top row), and then by our method with an identity covariance (second row). As can be seen from the table, the estimated tolerance is greater than the true tolerance for all cases (that is, the entry in the second row is greater than the first). In some cases, the estimated tolerance is very conservative, but in others it is only mildly conservative. Results held up under AR1 and CS covariance (Section 1.8 of supplementary material available at Biostatistics online). The table also shows one of the simulations we performed to show that the identity covariance provides conservative sample size estimates for a wide range of covariances as long as the dimension, β ∞ , and the marginal effect size are the same. Note that the tolerance estimates in the bottom row are greater than all the other rows when the observed power is adequate (over 70%), showing our method performs well with the identity matrix even for these non-identity covariance matrices. Note that the R program calculates and prints the power.
APPLICATION TO REAL DATASETS
The sample size method was applied to the two microarray datasets described in Section 1. Desmedt and others (2007) studied gene expression profiles from frozen tumor samples of node negative Features distributed multivariate normal. When SRF (survival-related features) = 1 then feature covariance matrix is identity; when SRF = 30, then feature covariance is block diagonal compound symmetric for the 30 survival-related features, within-block correlation 0.7, between-block correlation 0.0, independent features uncorrelated. B = 35 bootstraps in LOOBS. For the "Pure MC Eval. ofn", 400 samples of sizen were created and a risk predictor developed on each; then each risk predictor was applied to a separate set of 5000 samples to obtain estimates of the mean slopeβ indep n associated with future samples. Then "mean Tol" is average tolerance and "% within Tol" is the proportion of estimated slopes for which this difference was less than the "Tolerance" column. Whenn = 537, due to RAM memory issues simulation parameters were slightly different: 2000 samples of size n were created, and in each case 500 independent samples used to obtain estimates of τ 2 j,indep andβ indep n . breast cancer patients. The survival endpoint was defined as time from diagnosis to death from any cause or distant metastasis. Bonome and others (2008) studied gene expression signatures of stage III, high-grade primary ovarian cancer tumors. The survival endpoint was time from surgery to death from any cause. Patients were categorized by whether their tumors had been optimally or suboptimally debulked during surgery-a major prognostic factor. Both studies used Affymetrix U133A arrays. Results are shown in Table 4 , and details are presented in Sections 4.14.2 and 4.14.3 of supplementary material available at Biostatistics online. For the breast cancer data of Desmedt and others (2007) , the estimated sample size to achieve a tolerance of 0.10 was 207 for the distant metastases-free survival endpoint, or slightly larger than the 190 used in the study. The upper bound on the 90% confidence interval when n = 207 was 0.23. For the ovarian cancer dataset of Bonome and others (2008) , the estimated sample size is 120 to obtain a tolerance of 0.10 for an association with overall survival. However, there is greater uncertainty here; the upper bound on the 90% confidence interval is 0.33-much larger than the breast cancer dataset. This result makes biological sense because the ovarian tumors were a heterogeneous set of optimally and suboptimally debulked tumors, and a survival signature was only found associated with the suboptimal group.
In the PDA1 algorithm, each feature is centered at zero and scaled to have variance 1. This adjustment was found critical in the applications. The conditional score method for datasets of size n/4 sometimes would not converge and were omitted.
The proportional hazards assumption was evaluated for each dataset as described in Section 4.5 of supplementary material available at Biostatistics online (Song and others, 2002b) by introducing an Resampling studies on Rosenwald dataset and Loi dataset, and simulation study of a variety of covariances and linear predictors. For the resampling studies: first row is sample size and number of deaths (n (events)); second row is tolerance by resampling (T by Resamp), comparing the full dataset to the specified sample size (β n all −β n , where n all = 327 for the Loi dataset and n all = 240 for the Rosenwald dataset); third row is tolerance using identity covariance (T identity); AR1 and CS covariances are similar and appear in Section 1.18 of supplementary material available at Biostatistics online. For the simulation studies: first row is the sample size and number of deaths (n(events)). Rows 2-6 are different combinations of L and that produce the same marginal effect sizes. Without loss of generality, the first 9-30 features are the survival-related features, and the rest are independent noise features. The survival features are correlated. 1 is block compound symmetric (block CS), three blocks of size 3, and correlation parameter 0.4; 2 is block CS, three blocks of size 10, and correlation parameter 0.55; 3 is block AR1, three blocks of size 3, and correlation parameter 0.48; 4 is block AR1, three blocks of size 10, and correlation parameter 0.83. The L 1 , L 2 , L 3 , L 4 are set so each element is the same number and L k k L k = 1 for k = 1, 2, 3, 4. More results and details appear in Sections 1.6 and 1.8 of supplementary material available at Biostatistics online. † Observed power below 70%, so our method not recommended here.
interaction between time and the cross-validated risk prediction scores. For GSE7390, the p-value for the interaction was 0.74, and for E-GEOD-26712, the interaction p-value was 0.64.
DISCUSSION
In this paper, a method for determining the number of samples required to train a risk predictor on highdimensional data was developed. The method can be used in low dimensions as well. This approach can be used with any risk prediction algorithm that satisfies a set of conditions, and requires a pilot dataset in order to perform the estimation. If no adequate pilot dataset is available, then a method and associated programs are presented for estimating tolerance from a model. The sample size method produces an estimate of the optimal (asymptotic) risk prediction performance associated with an infinite training set. This estimate is itself potentially useful for study planning and evaluation of the clinical utility of an observed relationship between a bioassay (e.g. gene expression signature) and survival. The sample size method was shown to work well on simulated data. The method was applied to several real datasets and issues with hands-on use of the method were discussed. Similarly, the parametric estimate of tolerance was evaluated in simulations and resampling studies and performed well. GSE7390 is from the Desmedt and others (2007) study of breast cancer using Affymetrix U133A microarrays. E-Geod-26712 is from the Bonome and others (2008) study of ovarian cancer using Affymetrix U133A microarrays. Outcome is overall survival. α = 0.001 for the microarray datasets. Row heading descriptions: "Train n" is the number in the training set (original dataset); "Events" is the number of deaths in the training set; "Predictors" is the number of features; "β n " is the 10-fold cross-validated estimate of the Cox regression slope; "β ∞ " is the estimated optimal Cox slope; "Tolerance" is the user-specified tolerance for the sample size calculation; "n" is the sample size estimate; bottom row is the confidence interval from our CI method.
The method employs a novel LOOBS approach which is called tuned (LOOBS). Tuned LOOBS tunes the feature selection during bootstrap in order to nearly match the cross-validated stringency level. This reduces the bootstrap overdispersion. We are developing tuned methods for other prediction algorithms to make the bootstrap variance estimates more accurate, and this is an area of ongoing research.
The conditional score method was used to fit an EIV Cox regression. We investigated also the SIMEX method, but it was not feasible because fitting the extrapolation curve required manual inspection of plots. When the error is heterogeneous, the method of Li and Ryan (2004) can be adopted.
The sample size is chosen so that the tolerance is below a user-specified value. The standard deviation of the risk scores is 1. Thus, if the asymptotic risk score increases by one standard deviation, the increase in hazard will be e β ∞ . For example, if β ∞ = log(2), then the increase is 2-fold. If the tolerance was set to 0.10, then | log(2) − β n | < 0.10, so β n > log(2) − 0.1 ≈ 0.59. Thus, an increase of one standard deviation in the estimated risk scores would be expected to be associated with an e 0.59 ≈ 1.8 increase in the hazard. A limitation of our approach is the use of the Cox regression model. The model assumes that the asymptotic risk scores are linearly related to the log-hazard. This assumption is probably at best an approximation. On the other hand, simple linear models have proved effective in high-dimensional class prediction studies (Dudoit and others, 2002) , and therefore seem reasonable for risk prediction. A less parametric approach is possible, such as one based on the overall C criterion (Harrell and others, 1996) instead of the Cox regression slope, as suggested by a referee. By estimating the C criterion repeatedly for a range of sample sizes (less than or equal to the pilot dataset size), the relationship between the training size and C could be estimated, perhaps using a parametric non-linear regression. Fitting the model can produce an estimate of the optimal C, the C for a specified sample size, and the "c-tolerance" difference between the two.
Our method requires average power be over 70% to detect the marginal effect sizes. A formula for calculating marginal effect sizes was provided. The method of Hsieh and Lavori (2000) can be used to calculate the power and average power using, say, significance level 0.001 for PDA1.
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